UKDTN launched its first Phase 1b Alzheimer’s trial, dosing the first patient in Europe and streamlining setup across sites, with further trials and collaborations in progress.
Continue readingTaking the initiative in first in human trials
UKDTN launched its first Phase 1b Alzheimer’s trial, dosing the first patient in Europe and streamlining setup across sites, with further trials and collaborations in progress.
Continue reading